Suppr超能文献

[慢性肛裂的治疗:地尔硫䓬还是硝酸异山梨酯作为首选?]

[Treatment of chronic anal fissures: diltiazem or isosorbide dinitrate as first choice?].

作者信息

Boeker Eveline B, Kruijer M J P Marjan, Verbeek Paul C M

机构信息

Flevoziekenhuis, afd. Chirurgie, Almere, the Netherlands.

出版信息

Ned Tijdschr Geneeskd. 2011;155:A2594.

Abstract

Chronic anal fissures are a painful condition frequently seen in general practice, with an incidence of 2,5/1000 per year. According to the practice guidelines of the Dutch College of General Practitioners, isosorbide dinitrate 1% ointment (ISDN) is the treatment of first choice for chronic anal fissures. Systemic side-effects such as headache are reported in 27% of all cases. This side effect in combination with the frequent application of ISDN (4-6 times daily) leads to a low compliance for this therapy. A meta-analysis of the Cochrane Collaboration showed similar efficacy of diltiazem compared to ISDN. Diltiazem has several advantages: the application frequency is only twice daily, no systemic side-effects have been reported, the total costs of treatment are lower than the costs of ISDN and a standard preparation of diltiazem ointment is available. Therefore, diltiazem 2% ointment should be the first line treatment for chronic anal fissures.

摘要

慢性肛裂是全科医疗中常见的一种疼痛性病症,年发病率为2.5/1000。根据荷兰全科医师学院的实践指南,1%硝酸异山梨酯软膏(ISDN)是慢性肛裂的首选治疗方法。在所有病例中,有27%报告出现如头痛等全身性副作用。这种副作用加上ISDN的频繁使用(每日4 - 6次)导致该疗法的依从性较低。Cochrane协作网的一项荟萃分析表明,地尔硫䓬与ISDN疗效相似。地尔硫䓬有几个优点:使用频率仅为每日两次,未报告有全身性副作用,治疗总成本低于ISDN,且有地尔硫䓬软膏的标准制剂。因此,2%地尔硫䓬软膏应作为慢性肛裂的一线治疗药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验